Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Prevest Denpro Ltd

PREVEST

BSE

₹405.00-0.78%19 Oct 2026

Reports

Medical Equipment

Prevest Denpro Ltd

PREVEST

BSE

₹405.00

-0.78%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Medical Equipment

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹486Cr

Close Price

₹405.00

Industry

Medical Equipment

Price To Earnings

22.38

Price To Sales

6.47

Revenue

₹75Cr

Rev Gr TTM

Revenue Growth TTM

14.78%

PAT Gr TTM

PAT Growth TTM

14.92%

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	13	14	16	13	16	15	18	16	19	18	19	19
Growth YoY Revenue Growth YoY%				-0.2	23.4	9.8	13.6	18.0	14.6	23.5	2.7	20.9
Expenses ExpensesCr	9	9	10	9	10	10	12	10	12	13	12	12
Operating Profit Operating ProfitCr	4	4	6	5	6	5	7	5	7	6	7	7
OPM OPM%	33.5	32.8	37.0	33.8	35.7	34.9	35.5	33.7	35.8	31.4	36.5	35.5
Other Income Other IncomeCr	1	1	1	1	1	1	1	1	1	1	1	1
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	1	1	1	1
PBT PBTCr	5	5	6	5	6	6	7	6	7	6	8	8
Tax TaxCr	1	1	2	1	2	1	2	2	2	2	2	2
PAT PATCr	4	4	5	4	5	5	5	4	6	5	6	6
Growth YoY PAT Growth YoY%				-10.1	32.4	24.4	7.8	20.2	14.9	4.2	13.2	27.9
NPM NPM%	27.6	26.7	29.4	27.5	29.6	30.3	27.9	28.0	29.7	25.6	30.7	29.6
EPS EPS₹	3.0	3.0	4.0	3.1	4.0	3.8	4.3	3.7	4.6	3.9	4.8	4.7

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	13	14	16	13	16	15	18	16	19	18	19	19
Growth YoY Revenue Growth YoY%				-0.2	23.4	9.8	13.6	18.0	14.6	23.5	2.7	20.9
Expenses ExpensesCr	9	9	10	9	10	10	12	10	12	13	12	12
Operating Profit Operating ProfitCr	4	4	6	5	6	5	7	5	7	6	7	7
OPM OPM%	33.5	32.8	37.0	33.8	35.7	34.9	35.5	33.7	35.8	31.4	36.5	35.5
Other Income Other IncomeCr	1	1	1	1	1	1	1	1	1	1	1	1
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	1	1	1	1
PBT PBTCr	5	5	6	5	6	6	7	6	7	6	8	8
Tax TaxCr	1	1	2	1	2	1	2	2	2	2	2	2
PAT PATCr	4	4	5	4	5	5	5	4	6	5	6	6
Growth YoY PAT Growth YoY%				-10.1	32.4	24.4	7.8	20.2	14.9	4.2	13.2	27.9
NPM NPM%	27.6	26.7	29.4	27.5	29.6	30.3	27.9	28.0	29.7	25.6	30.7	29.6
EPS EPS₹	3.0	3.0	4.0	3.1	4.0	3.8	4.3	3.7	4.6	3.9	4.8	4.7

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	56	63	72	75
Growth Revenue Growth%		11.7	13.9	14.8
Expenses ExpensesCr	37	41	47	49
Operating Profit Operating ProfitCr	20	22	25	26
OPM OPM%	35.2	35.0	34.4	34.8
Other Income Other IncomeCr	3	4	5	5
Interest Expense Interest ExpenseCr	0	0	0	0
Depreciation DepreciationCr	1	2	2	2
PBT PBTCr	21	24	28	29
Tax TaxCr	5	6	7	7
PAT PATCr	16	18	20	22
Growth PAT Growth%		12.5	12.9	14.9
NPM NPM%	28.6	28.8	28.5	28.9
EPS EPS₹	13.4	15.1	17.1	18.1

Financial Year	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	56	63	72	75
Growth Revenue Growth%		11.7	13.9	14.8
Expenses ExpensesCr	37	41	47	49
Operating Profit Operating ProfitCr	20	22	25	26
OPM OPM%	35.2	35.0	34.4	34.8
Other Income Other IncomeCr	3	4	5	5
Interest Expense Interest ExpenseCr	0	0	0	0
Depreciation DepreciationCr	1	2	2	2
PBT PBTCr	21	24	28	29
Tax TaxCr	5	6	7	7
PAT PATCr	16	18	20	22
Growth PAT Growth%		12.5	12.9	14.9
NPM NPM%	28.6	28.8	28.5	28.9
EPS EPS₹	13.4	15.1	17.1	18.1

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	12	12	12
Reserves ReservesCr	77	94	113
Current Liabilities Current LiabilitiesCr	6	6	7
Non Current Liabilities Non Current LiabilitiesCr	1	1	1
Total Liabilities Total LiabilitiesCr	95	113	133
Current Assets Current AssetsCr	68	86	106
Non Current Assets Non Current AssetsCr	27	27	27
Total Assets Total AssetsCr	95	113	133

Financial Year	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	12	12	12
Reserves ReservesCr	77	94	113
Current Liabilities Current LiabilitiesCr	6	6	7
Non Current Liabilities Non Current LiabilitiesCr	1	1	1
Total Liabilities Total LiabilitiesCr	95	113	133
Current Assets Current AssetsCr	68	86	106
Non Current Assets Non Current AssetsCr	27	27	27
Total Assets Total AssetsCr	95	113	133

Consolidated

Standalone

Financial Year	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	12	15	15
Investing Cash Flow Investing Cash FlowCr	-2	-1	-2
Financing Cash Flow Financing Cash FlowCr	0	-1	-1
Net Cash Flow Net Cash FlowCr	10	12	12
Free Cash Flow Free Cash FlowCr	8	13	13
CFO To PAT CFO To PAT%	72.0	81.6	72.3
CFO To EBITDA CFO To EBITDA%	58.6	67.1	59.9

Financial Year	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	12	15	15
Investing Cash Flow Investing Cash FlowCr	-2	-1	-2
Financing Cash Flow Financing Cash FlowCr	0	-1	-1
Net Cash Flow Net Cash FlowCr	10	12	12
Free Cash Flow Free Cash FlowCr	8	13	13
CFO To PAT CFO To PAT%	72.0	81.6	72.3
CFO To EBITDA CFO To EBITDA%	58.6	67.1	59.9

Consolidated

Standalone

Financial Year	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	424	514	410	486
Price To Earnings Price To Earnings	26.3	28.3	20.0	22.4
Price To Sales Price To Sales	7.2	7.9	5.5	6.5
Price To Book Price To Book	4.8	4.9	3.3	3.9
EV To EBITDA EV To EBITDA	18.9	20.5	13.7	15.9
Profitability Ratios Profitability Ratios
GPM GPM%	68.2	69.3	70.7	70.7
OPM OPM%	35.2	35.0	34.4	34.8
NPM NPM%	28.6	28.8	28.5	28.9
ROCE ROCE%	24.2	23.0	22.1	22.1
ROE ROE%	18.2	17.2	16.4	16.4
ROA ROA%	17.0	16.1	15.4	15.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	424	514	410	486
Price To Earnings Price To Earnings	26.3	28.3	20.0	22.4
Price To Sales Price To Sales	7.2	7.9	5.5	6.5
Price To Book Price To Book	4.8	4.9	3.3	3.9
EV To EBITDA EV To EBITDA	18.9	20.5	13.7	15.9
Profitability Ratios Profitability Ratios
GPM GPM%	68.2	69.3	70.7	70.7
OPM OPM%	35.2	35.0	34.4	34.8
NPM NPM%	28.6	28.8	28.5	28.9
ROCE ROCE%	24.2	23.0	22.1	22.1
ROE ROE%	18.2	17.2	16.4	16.4
ROA ROA%	17.0	16.1	15.4	15.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	LAXMIDENTL	HSIL	DENTALKART	PREVEST	EARKART	APRAMEYA	MADHAVBAUG
Market CapitalizationMkt CapCr	1,002	898	763	486	172	165	165
Close PriceClose₹	182.10	618.00	440.00	405.00	125.35	86.50	156.65
IndustryIndustry	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment
Price To EarningsPE	32.17	40.16	65.19	22.38	50.34	32.28	18.41
Price To SalesPS	3.49	3.88	2.53	6.47	3.19	2.99	1.54
RevenueRevenueCr	287	232	302	75	54	55	107
Revenue Growth TTMRev Gr TTM%	17.1%	117.4%	17.9%	14.8%	25.4%	-59.4%	18.9%
PAT Growth TTMPAT Gr TTM%	57.4%	126.3%	-30.2%	14.9%	-28.4%	-68.2%	25.7%

	LAXMIDENTL	HSIL	DENTALKART	PREVEST	EARKART	APRAMEYA	MADHAVBAUG
Market CapitalizationMkt CapCr	1,002	898	763	486	172	165	165
Close PriceClose₹	182.10	618.00	440.00	405.00	125.35	86.50	156.65
IndustryIndustry	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment
Price To EarningsPE	32.17	40.16	65.19	22.38	50.34	32.28	18.41
Price To SalesPS	3.49	3.88	2.53	6.47	3.19	2.99	1.54
RevenueRevenueCr	287	232	302	75	54	55	107
Revenue Growth TTMRev Gr TTM%	17.1%	117.4%	17.9%	14.8%	25.4%	-59.4%	18.9%
PAT Growth TTMPAT Gr TTM%	57.4%	126.3%	-30.2%	14.9%	-28.4%	-68.2%	25.7%